Priority strategy of new nasal continuous positive airway pressure to treat neonatal respiratory failure

Objective To explore the effect of a new nasal continuous positive airway pressure(NCPAP) which is priority strategic treatment for neonatal respiratory failure.Methods Fifty cases of neonatal respiratory failure in the control group were treated from January 2006 to January 2008 by using simple water seal bottle NCPAP;and 60 patients for the treatment group used the new NCPAP(Germany Stephan company,CPAP-B type) in the treatment of neonatal respiratory failure from February 2008 to June 2010.Group NCPAP was applied with new treatment after being admitted to hospital,the first application of oxygen hood 1 hr to 4hrs,the control group′s oxygenation did not improve by using of simple water seal bottle NCPCP.The results of the two groups of children were compared in terms of NCPAP treatment success rate,NCPAP oxygen therapy,the incidence of lung leak and efficacy.Results The success rate in treatment group with NCAPA was 85.0%,and that of control group was 66.0%;NCPAP oxygen therapy treatment group(3.1±0.4) d,the control group(4.3±0.5) d;lung leak rate of the treatment group was 3.3% in the control group was 4.0%;total effective rate was 86.7% in the treatment group and control group was 70.0%.NCPAP treatment success rate of the two groups,oxygen therapy,there were significant differences in efficiency(P0.05) of treatment group,the incidence of lung leak slightly lower than the control group,but the difference between the two groups was not significant(P0.05).Conclusion The first strategy to implement the new NCPAP treatment of neonatal respiratory failure could significantly improve the efficacy and reduce the oxygen therapy to reduce the rate of invasive ventilation.